Argus Research analyst David Toung maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 14. The company’s shares ...
Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...
We recently compiled a list of the 10 Best Momentum Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 82 tables and 82 figures, this 175-page report ?Global Endoscopy Devices Market 2023-2033 by Device Type, Hygiene, ...
So far, BSX stock has risen 19% year-to-date. Separately, CROX reports earnings tomorrow. Will the stock pop on the news? See ...
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.
In addition, technological advancements such as the increasing use of AI, predictive analysis, and advanced algorithms are ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DOJoPAWP.js ...
Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...
Boston Scientific, with approximately 10,000 employees in Minnesota, reported a fourth-quarter adjusted net profit of $1 ...
The company expects its 2025 adjusted earnings to be in the range of $2.80 to $2.87 per share, above analysts' average expectation of $2.81 at the midpoint, according to data compiled by LSEG. Boston ...